Agenda & Learning Objectives

 

 Participants in this program will be able to:

  • Differentiate nutrition as primary therapy for IBD vs. nutritional support and replacement
  • Explore new therapies in IBD with emphasis on individualized therapy and strategic sequencing
  • Compare endoscopic and radiologic imaging advances in technology for the evaluation of small bowel Crohn’s disease
  • Discuss rheumatological manifestations in inflammatory bowel disease
  • Examine checkpoint inhibitor colitis, NSAID colopathy and infectious colidites to differentiate IBD mimickers from real IBD
  • Survey current IBD literature
Time
Title/Topic
Speakers/Facilitators
08:30  Opening Remarks  CO-CHAIRS: 
Alain Bitton & John Marshall

(1) Nutrition Therapy for IBD: A Primer for Adult GI

08:40 1.1 Interactive Case Presentation
  • Case to highlight learning objectives of the plenary session
MODERATOR: John Marshall
08:55 1.2 State-of-the-Art Plenary Presentation
Nutrition Therapy for IBD: A Primer for Adult GI
Session Objectives:
  • Differentiate nutrition as primary therapy for IBD versus nutritional support and replacement
  • Review proposed dietary therapies, their components and their evidence
  • Discuss what we can tell the patient who asks what diet to follow
Eytan Wine
University of Alberta

09:15

1.3 Expert Panel Discussion/Q&A
MODERATOR: John Marshall
PANEL: Anne Griffiths, Eytan Wine + 2 TBC
09:35 E-Mentoring in IBD Lit Quiz – Round One MODERATOR: Alain Bitton

(2) Therapeutics in IBD: Many new choices, but who's on first?

09:40 2.1 Case-based Workshop Breakout Session
  • Case to highlight learning objectives of the plenary session
FACILITATORS:
Daniel Baumgart, Charles Bernstein, Brian Bressler, Brian Feagan, Jennifer Jones, Cynthia Seow + 2 TBC
10:30
Refreshment Break
10:45 2.2 State-of-the-Art Plenary Presentation
Therapeutics in IBD: Many new choices, but who's on first?
Session Objectives:
  • Broad discussion of new therapies in IBD with emphasis on individualized therapy and strategic sequencing
  • Which factors do we consider in selecting a therapy? What is the role of patient preference?
  • Therapeutic strategies, treatment sequencing: What is first line? What is second line?
Brian Feagan
Western University
11:05 2.3 Expert Panel Discussion/Q&A MODERATOR: Alain Bitton
PANEL: Charles Bernstein, Brian Bressler, Brian Fegan, Jennifer Jones
11:25 E-Mentoring in IBD Lit Quiz – Round Two MODERATOR: Alain Bitton

(3) Technological Advances in IBD

11:30 3.1 State-of-the-Art Case-based Tandem Plenary Presentation
Evaluating Small Bowel Crohn's Disease:
What's in our toolbox?
Session Objectives:
  • Radiologist to focus on magnetic resonance imaging (MRI) including standardized reporting, computed tomography (CT)
    • How safe is CT in 2019? When do we worry about radiation dose?
    • What features matter on MRI? What is current best practice for technique (e.g. contrast)?
    • How to differentiate inflammatory vs. fibrotic  stricture?
  • Gastroenterologist to review new techniques and technology including: advanced ultrasound (US), capsule, double-balloon, and novel endoscopy (magnification, chromo, etc). When might capsule endoscopy fit in our algorithms?
Radiologist:
Luis Guimarães
University of Toronto
 
Gastroenterologist:
Bincy Abraham
Weill Cornell Medical College; Texas A&M University
12:10 3.2 Expert Panel Discussion/Q&A MODERATOR: John Marshall
PANEL: Bincy Abraham, Daniel Baumgart, Charles Bernstein, Luis Guimarães
12:25 
Lunch

(4) Extraintestinal Manifestations in IBD: Rheumatological

13:25  4.1 Case-based Workshop Breakout Session
  • Case to highlight learning objectives of the plenary session
FACILITATORS:
Glen Hazlewood, Karen Kroeker, Cynthia Seow, Hillary Steinhart + 4 TBC

 
14:15  4.2 State-of-the-Art Plenary Presentation
Rhematological Manifestations in IBD
Session Objectives:
  • Differentiate between IBD arthropathy, drug-induced arthropathy and comorbid immune mediated inflammatory disorders (IMID)
  • Discuss axial and peripheral spondyloarthropathy? How can GI assess the patient with joint pain?
  • How can gastroenterology and rheumatology best work together to choose the best biologic?
    • Can you combine biologics?
  • Focus on common clinical scenarios
  • Review the importance of collaboration between the specialties
Glen Hazlewood
University of Calgary
14:35 4.3 Expert Panel Discussion/Q&A MODERATOR: Cynthia Seow
PANEL: Glen Hazlewood, Hillary Steinhart + 2 TBC
14:55  E-Mentoring in IBD Lit Quiz – Round Three MODERATOR: Alain Bitton

(5) Inflammatory Bowel Disease Mimickers

15:00 5.1 Interactive Case Presentation
  • Case to highlight learning objectives of the plenary session
MODERATOR: Karen Kroeker
15:15 5.2 State-of-the-Art Plenary Presentation
IBD Mimickers
Session Objectives:
  • Review checkpoint inhibitor colitis, NSAID colopathy and infectious colidites (e.g. TB)
  • How do you differentiate IBD mimickers from real IBD?
  • Discuss treatment of checkpoint-inhibitor colopathy
Franck Carbonnel
University Paris Sud
15:35 5.3 Expert Panel Discussion/Q&A MODERATOR: Karen Kroeker
PANEL: Paul Beck, Franck Carbonnel, Jennifer Jones, Remo Panaccione
15:50 Closing Remarks – Evaluation CO-CHAIRS: Alain Bitton & John Marshall
16:00 Celebrating 20 Years of Mentoring in IBD: The Richard N. Fedorak Award of Distinction  
16:15 
Meeting of the Minds Celebratory Reception

 

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.